|
|
 |
|
Total Number of Holdings (excluding cash): 51
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$45,102.00 |
2.45% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$41,570.10 |
2.25% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$41,569.30 |
2.25% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$40,647.14 |
2.20% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$39,896.93 |
2.16% |
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$39,697.02 |
2.15% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$39,661.28 |
2.15% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$39,406.28 |
2.14% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$39,351.91 |
2.13% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$39,369.08 |
2.13% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$39,025.79 |
2.12% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$39,002.18 |
2.11% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$38,722.50 |
2.10% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,551.68 |
2.09% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$38,364.20 |
2.08% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$38,063.61 |
2.06% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$37,757.48 |
2.05% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$37,586.30 |
2.04% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$37,515.00 |
2.03% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$37,327.50 |
2.02% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$37,272.40 |
2.02% |
| Waters Corporation |
WAT |
941848103 |
121 |
$37,161.52 |
2.02% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$36,994.05 |
2.01% |
| Steris Plc |
STE |
G8473T100 |
173 |
$37,091.20 |
2.01% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$36,794.84 |
2.00% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$36,745.03 |
1.99% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$36,526.50 |
1.98% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$36,576.98 |
1.98% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$36,598.38 |
1.98% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$36,262.97 |
1.97% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$36,215.42 |
1.96% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$35,792.64 |
1.94% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$35,555.45 |
1.93% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$35,556.76 |
1.93% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$35,606.01 |
1.93% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$35,403.90 |
1.92% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$35,360.00 |
1.92% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$35,444.99 |
1.92% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$35,256.00 |
1.91% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$35,035.65 |
1.90% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$34,648.38 |
1.88% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$34,442.10 |
1.87% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$34,372.24 |
1.86% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$34,307.84 |
1.86% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$34,320.60 |
1.86% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$33,799.12 |
1.83% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$33,599.22 |
1.82% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$32,162.81 |
1.74% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$30,671.91 |
1.66% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$22,560.45 |
1.22% |
| US Dollar |
$USD |
|
7,587 |
$7,586.50 |
0.41% |
| Japanese Yen |
$JPY |
|
44,982 |
$287.24 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|